DAVENPORT & Co LLC
Source: SEC Form 13F · as of Mar 2026DAVENPORT & Co LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $132.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$132.6M
BioSniper AIPage context preserved
Prepared research question
What matters most for Sanofi (SNY)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| SNYSanofi | 2,094,962 | $100.2M |
| IONSIONIS PHARMACEUTICALS INC | 238,238 | $17.9M |
| TEVATeva Pharmaceutical Industries Limited | 124,086 | $3.7M |
| GILDGILEAD SCIENCES, INC. | 24,218 | $3.4M |
| CGTXCOGNITION THERAPEUTICS INC | 2,892,808 | $2.2M |
| GMABGenmab A/S | 44,901 | $1.2M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 16,779 | $926K |
| ARGXARGENX SE | 935 | $683K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,842 | $609K |
| REGNREGENERON PHARMACEUTICALS, INC. | 488 | $377K |
| AXSMAxsome Therapeutics, Inc. | 1,800 | $304K |
| ROIVRoivant Sciences Ltd. | 10,600 | $294K |
| SIGASIGA TECHNOLOGIES INC | 50,000 | $268K |
| BBIOBridgeBio Pharma, Inc. | 3,300 | $245K |
| INCYIncyte Corp. | 2,569 | $242K |
| LTRNLantern Pharma Inc. | 23,814 | $33K |
| PDSBPDS Biotechnology Corp | 10,000 | $6K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.